Oramed Pharmaceuticals Inc. (TLV:ORMP)
Israel · Delayed Price · Currency is ILS · Price in ILA 825.70
-12.50 (-1.49%)
Nov 20, 2025, 5:27 PM IDT
Oramed Pharmaceuticals Revenue
Oramed Pharmaceuticals had revenue of $2.00M USD in the twelve months ending September 30, 2025.
Revenue (ttm)
$2.00M
Revenue Growth
n/a
P/S Ratio
50.85
Revenue / Employee
$500.00K
Employees
4
Market Cap
336.76M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.34M | -1.36M | -50.43% |
| Dec 31, 2022 | 2.70M | -9.00K | -0.33% |
| Dec 31, 2021 | 2.71M | 9.00K | 0.33% |
| Aug 31, 2021 | 2.70M | -9.00K | -0.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.84B |
| Novolog (Pharm-Up 1966) | 2.04B |
| Ilex Medical | 927.57M |
| Kamada | 578.74M |
| SofWave Medical | 255.13M |
| InterCure | 243.12M |
| BrainsWay | 162.56M |
Oramed Pharmaceuticals News
- 6 days ago - Oramed (ORMP) Implements Stockholder Rights Agreement - GuruFocus
- 6 days ago - Oramed Pharmaceuticals GAAP EPS of $1.26 - Seeking Alpha
- 6 days ago - Oramed Reports Fiscal Third Quarter 2025 Financial Results - PRNewsWire
- 6 days ago - ORAMED PHARMACEUTICALS INC. DECLARES DIVIDEND DISTRIBUTION OF COMMON STOCK PURCHASE RIGHTS - PRNewsWire
- 4 weeks ago - Oramed Releases Letter to Shareholders, Highlighting Developments in its Oral Insulin Program, Significant Investment Appreciation, and Upcoming Growth Initiatives - PRNewsWire
- 7 weeks ago - Oramed Pharmaceuticals (ORMP) Receives $13 Million from Scilex for Warrants - GuruFocus
- 7 months ago - Oramed Pharmaceuticals invests $36.9 M in Alpha Tau Medical - Seeking Alpha
- 7 months ago - Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals - GlobeNewsWire